F.D.A. Approves New Menopause Drug
From The New York Times:
Millions of menopausal women coping with hot flashes and night sweats now have a new nonhormonal treatment option as the FDA approved LynkUet. This is a significant breakthrough for people who can’t or prefer not to take estrogen.
Experts describe it as a turning point in addressing gaps in menopause care and equity. Clinical trial results, health access, and next steps for women interested in the drug are all covered.